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Case presentation
Dr. Boldrini: P.G., male, 66 year old was evaluated in our
ward on 27 April 2009 for the persistence at home of
watery diarrhoea and abdominal pain over the previous
10 days.
For these symptoms, he had taken rifaximine and lop-
eramide without benefit. He denied fever, blood or mucus
in the stools. He had neither family history of inflammatory
bowel disease, nor had travelled abroad over the prior
months. In his medical history, in 1997 an idiopathic
dilated cardiomyopathy was diagnosed when the patient
was admitted to the hospital for stroke. Since then he had
taken warfarin, along with digoxin, ramipril, furosemide,
lansoprazole; he reported intolerance to beta blockers.
Upon admission, the patient was conscious and co-oper-
ative, blood pressure 100/60 mmHg, heart rate 90 beats/
min., and normal O2 saturation. Clinical examination was
substantially normal; except for the presence of bilateral leg
edema. BMI was 24. We performed an ECG (Fig. 1) that
showed normal sinus rhythm with left bundle branch block,
and a short run of ventricular tachycardia; an X-ray of the
abdomen was normal, whereas a chest radiography revealed
‘‘cardiomegaly’’ with initial apical flow distribution.
Biochemistry showed PTL 496,000/mm3, the prothrom-
bin time exceeding the therapeutic range, severe protein
deficiency with 1.85 g/dl albumin, elevation of CRP
(3.56 mg/dl), mild hypokalemia, severe iron deficiency
(lowered serum iron and serum ferritin without transferrin
elevation).
Mild rehydration and albumin supplementation were
started during the initial days, then replaced by total par-
enteral nutrition.
Diagnosis
Dr. Boldrini, Dr. Romagnoli: Thyroid function was nor-
mal and stool culture negative; both tissue transglutamin-
ase (100 U/ll) IgA endomysial antibodies were positive,
with total serum IgA in the normal range.
In order to perform upper gastrointestinal (UGI)
endoscopy, warfarin was discontinued and replaced by
enoxaparin: UGI endoscopy showed appreciable reduction
with scalloped configuration; histopathology examination
documented partial villous atrophy with increased num-
ber of intra-epithelial lymphocytes (Lesion 3A, Marsh
Classification).
Echocardiography showed severe dilatation and global
hypokinesis of left ventricle (ejection fraction 25%) with
functional mitral insufficiency, severe left atrial enlarge-
ment, presence of ventricular dyssynchrony.
Twelve hours after the upper GI endoscopy the patient
presented confusion and dysarthria: a head CT scan showed
an acute ischemic lesion in the left cerebellar hemisphere
whereas carotid Doppler scan was normal. The symptoms
disappeared on the following day. The patient was dis-
charged after 20 days with a diagnosis of ‘‘celiac disease
with severe malnutrition, cerebellar ischemic stroke
(probably cardioembolic) in patient with idiopathic dilated
cardiomyopathy’’.
This case record was selected for the ‘‘Casi Clinici Gymnasium’’
session at the 2009 SIMI Annual Congress in Rome, and was
reviewed by a Committee composed of Maria Domenica Cappellini,
Nicola Montano and Luigi Pagliaro.
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Discussion
Prof. Pietrangelo: The association of celiac disease and
cardiomyopathy has been recently reported.
One study of 52 patients reports an increased prevalence
of celiac disease (5.7%) in patients with dilated cardio-
myopathy [1]; in another study De Bem shows a preva-
lence of 2.7% for celiac disease in South Brazilian
precardiac transplant patients with advanced cardiomyop-
athy [2]. An Italian study of 187 patients with myocarditis
reveals that 4.4% of them are positive for antiendomysial
antibodies with duodenal endoscopic and histological evi-
dence of celiac disease [3]; Prati et al. [4] confirm that
patients with end-stage heart failure are at increased risk
for celiac disease as compared to the general population.
Pathogenic mechanisms
Prof Pietrangelo, Dr. Romagnoli: Several pathogenic
mechanisms have been proposed for the development of
cardiomyopathy in the course of celiac disease.
It is known that a reciprocal negative interaction
between the heart and small intestine can occur when either
organ is severely impaired. Intestinal absorption may be
compromised in patients with congestive cardiac disease or
idiopathic dilated cardiomyopathy, and celiac disease can
affect the absorption of essential nutrients, leading to
structural and functional abnormalities of cardiomyocytes
that may exacerbate or precipitate an idiopathic dilated
cardiomyopathy [2, 5].
Abnormalities of intestinal permeability in patients with
celiac disease may lead to increased systemic absorption of
various luminal antigens or infectious agents that may
cause myocardial damage through immune-mediated
mechanisms [6–8].
Finally, myocardial injury may be secondary to an
immune response directed against an antigen present in
both the myocardium and the small intestine [9].
The hypothesis of autoimmune disorders is strongly
suggested by a number of data: the presence of serological
detection of anti endomysial antibody and cardiac auto-
antibodies, the HLA profile, negative PCR studies for
cardiotropic viruses, responsiveness to a gluten-free diet
and immunosuppressive therapy [3].
Other authors propose that heart failure might result
from other conditions associated with celiac disease as
diabetes, thyroid disorders, vasculitis etc, in these cases
anti endomysial antibody would merely ‘‘mark’’ a popu-
lation with known risk for cardiac involvement [4].
As far as an inherited hypothesis is concerned, Not et al.
find a higher prevalence of celiac disease in patients with
sporadic or inherited dilated cardiomyopathy and a higher
prevalence of IgA anti-tissue transglutaminase positive
serology in relatives with echocardiographic abnormalities;
these elements suggest that immune-mediated mechanisms
are active in subsets of patients/families. However, gluten
intolerance cannot be considered causative since celiac
disease seems to be associated but does not co-segregate
with dilated cardiomyopathy in familial cases [10].
Role of diet
Dr. Romagnoli, Dr. Boldrini: If the association between
these two conditions were true, the gluten-free diet should
have an important role. Frustaci et al. screened the serum of
187 consecutive patients with myocarditis: 13 were posi-
tive for IgA anti-tissue transglutaminase, and 9 (4.4%)—5
myocarditis associated with heart failure and 4 with ven-
tricular dysrhythmias with Lown class III/IVa—exhibited
duodenal endoscopic and histological evidence of CD. The
Fig. 1 ECG: normal sinus rhythm with left bundle branch block, and a short run of ventricular tachycardia
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patients with myocarditis and heart failure received
immunosuppression and a gluten-free diet, which elicited
recovery of cardiac volumes and function. The patients
with dysrhythmia, after being put on a gluten-free
diet alone, showed improvement in the dysrhythmia (Lown
class I). The authors conclude that in these patients
immunosuppression and a gluten-free diet can be effective
therapeutic options [3].
An Italian study investigated patients presenting idio-
pathic dilated cardiomyopathy associated with celiac dis-
ease: they show a greater decrease in serum total carnitine
levels than patients presenting isolated form of idiopathic
dilated cardiomyopathy; the gluten-free diet in these
patients led to a progressive increase in serum levels of this
micronutrient (an important cofactor for the metabolism of
fatty acids that could play an important role in the
improvement of heart performance) [11].
True or false association?
Dr. Romagnoli: Other authors do not find an association
between celiac disease and subsequent myocarditis, car-
diomyopathy or pericarditis in population studies [12].
Vizzardi et al. [13] indicate a similar prevalence of coeliac
disease in patients with dilated cardiomyopathy in com-
parison to the Italian general population (1%): for the
authors the presence of confounding factor associated with
both coeliac disease and dilated cardiomyopathies may
explain the lack of association reported in others studies,
mostly based on small sample size.
Bardella et al. [14], assessed the prevalence of cardiac
involvement in patients with inflammatory bowel disease
and in patients with celiac disease: the prevalence was
similar, indicating that cardiac damage is not specific for
celiac disease.
Other authors show that anti-transglutaminase antibod-
ies can be found in cardiological patients, and these anti-
bodies are related to the severity or extension of the
myocardial tissue lesion, suggesting a loss of specificity for
these antibodies in celiac disease [15]; in rat models of
cardiac failure in fact an upregulation of mRNA for anti-
tissue transglutaminase has been reported [16].
Returning to our patient
Dr. Boldrini: Going back to our patient and his early
cardiac l history, in 1998 a coronary angiography was
performed, but it did not reveal any vascular alteration.
Laboratory tests were performed in 1997 and showed
hypoalbuminemia (3 g/dl) and iron deficiency: no further
etiologic investigations were performed on that occasion.
We can only hypothesize that the patient might have pre-
sented at that time early signs of an incipient celiac disease.
This hypothesis could be supported by literature data
showing that only 25% of celiac patients have a history of
typical gastrointestinal symptoms, while iron deficiency is
the most common manifestation of the disease and is
present in 75% of cases [14].
Ventura et al. [17] examined the relationship between
the prevalence of autoimmune disorders in celiac disease
and the duration of exposure to gluten: the prevalence of
autoimmune disorders in celiac disease is related to the
duration of gluten exposure.
Possibly, cardiomyopathy in our patient was the result of
very long gluten introduction and appeared as an autoim-
mune-related response to celiac disease. We may also
wonder whether a link exists between the advanced cardiac
disease (represented by dyssynchrony) and the current
‘‘major symptoms’’ of celiac disease [18].
Six weeks after good adherence to a gluten-free diet, the
patient presented with persistent abdominal pain and diar-
rhoea; abdominal TC showed mesenteric thickening and
enlarged mesenteric lymph nodes the histopathologic
examination of jejunal and duodenal lesions were negative
for lymphoma.
Conclusion
Prof. Pietrangelo: In summary, considering the available
literature data, a possible association between celiac dis-
ease and cardiomyopathy clearly emerges. Unfortunately in
our patient, neither endomyocardial biopsy nor cardiac
MRI was performed to clearly prove cardiac involvement
and reach a definite diagnosis.
In conclusion, the idiopathic dilated cardiomyopathy of
our patient could represent the end stage of an inflam-
matory autoimmune cardiomyopathy; if so, the gluten-free
diet could represent a tool to stop the autoimmune anti-
myocardial phenomena leading to subsequent improve-
ment of clinical and ventricular functionality. This case
clearly indicates that it is advisable to offer to all patients
with cardiomyopathy and celiac disease an endomyocar-
dial biopsy for a better histological and diagnostic
definition.
What might be the role of immunosuppressor therapy
associated with gluten-free diet? This case report notes the
importance of the pathogenetic link between celiac disease
and cardiomyopathy and warrants future studies on intes-
tinal and myocardial autoimmunity.
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